Pulmonx Net Profit Margin 2019-2023 | LUNG
Pulmonx Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2023-12-31 | $0.07B | $-0.06B | -88.41% |
2023-09-30 | $0.07B | $-0.06B | -93.85% |
2023-06-30 | $0.06B | $-0.06B | -98.36% |
2023-03-31 | $0.06B | $-0.06B | -101.72% |
2022-12-31 | $0.05B | $-0.06B | -109.26% |
2022-09-30 | $0.05B | $-0.06B | -109.43% |
2022-06-30 | $0.05B | $-0.05B | -103.85% |
2022-03-31 | $0.05B | $-0.05B | -104.00% |
2021-12-31 | $0.05B | $-0.05B | -102.08% |
2021-09-30 | $0.04B | $-0.05B | -102.27% |
2021-06-30 | $0.04B | $-0.04B | -92.86% |
2021-03-31 | $0.03B | $-0.04B | -111.76% |
2020-12-31 | $0.03B | $-0.03B | -94.12% |
2020-06-30 | $0.02B | $-0.02B | -104.55% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.293B | $0.069B |
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
10x Genomics (TXG) | United States | $3.489B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
Axonics (AXNX) | United States | $3.396B | 0.00 |
Enovis (ENOV) | United States | $3.029B | 23.01 |
Azenta (AZTA) | United States | $2.925B | 238.46 |
Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
Privia Health (PRVA) | United States | $2.183B | 96.84 |
Schrodinger (SDGR) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.231B | 30.12 |
Phreesia (PHR) | United States | $1.169B | 0.00 |
Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
Standard BioTools (LAB) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
Talkspace (TALK) | United States | $0.519B | 0.00 |
Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.148B | 0.00 |
MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
Outset Medical (OM) | United States | $0.131B | 0.00 |
TruBridge (TBRG) | United States | $0.116B | 4.94 |
111 (YI) | China | $0.087B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
Movano (MOVE) | United States | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |